Showing results (11-20 of 161) with videos related to
Sort By:
Pageof 17
BMJ Oncology|September 9, 2025
Concordance with CONSORT-AI guidelines in reporting of randomised controlled trials investigating artificial intelligence in oncology: a systematic reviewDavid Chen, Kristen Arnold, Ronesh Sukhdeo, et al.BMJ Oncology|August 6, 2025
Analysis of control arms in oncology randomised trials in Brazil: a cross-sectional studyAna Elisa Boracini Sanches, Luiza Aleixo Barros Leite Fadul, Debora Aparecida Pires de Campos Zuccari, et al.BMJ Oncology|June 24, 2025
Reduced duration adjuvant trastuzumab in the treatment of patients with HER2-positive breast cancer: a meta-analysis of randomised controlled non-inferiority trials including IPD dataHelena M Earl, Louise Hiller, Janet A Dunn, et al.BMJ Oncology|July 15, 2025
Chemotherapy and radiotherapy use in patients with lung cancer in Australia, Canada, the UK and Norway 2012-2017: an ICBP population-based studyMatthew E Barclay, Sean McPhail, Shane A Johnson, et al.BMJ Oncology|December 1, 2025
KRAS-targeted therapies in cancer: novel approaches and overcoming resistanceDaolin Tang, Guido Kroemer, Rui KangBMJ Oncology|January 31, 2025
Choosing Wisely in oncology: are guidelines effective at preventing unnecessary diagnostics? The example of surveillance positron emission tomography for patients with localised colorectal cancerDaniel A Goldstein, Roi Tschernichovsky, Talish Razi, et al.BMJ Oncology|January 31, 2025
Artificial intelligence across oncology specialties: current applications and emerging toolsJohn Kang, Kyle Lafata, Ellen Kim, et al.BMJ Oncology|January 31, 2025
Does radiofrequency ablation of the lower oesophagus allow for clonal expansion of highly mutated neosquamous epithelium?Fahire Goknur Akarca, Nicholas J Shaheen, Matthew D StachlerBMJ Oncology|March 6, 2025
UK-based clinical testing programme for somatic and germline BRCA1/2, ATM and CDK12 mutations in prostate cancer: first resultsD Gareth Evans, George Burghel, Helene Schlecht, et al.BMJ Oncology|March 6, 2025
Genetics, primary care records and lifestyle factors for short-term dynamic risk prediction of colorectal cancer: prospective study of asymptomatic and symptomatic UK Biobank participantsSamantha Ip, Hannah Harrison, Juliet A Usher-Smith, et al.Pageof 17